News Release

CME Group Inc. Reports Solid Third-Quarter 2009 Financial Results

Thu Oct 29 2009

CHICAGO, Oct. 29 /PRNewswire-FirstCall/ -- CME Group Inc. (NASDAQ: CME) today reported that third-quarter GAAP total revenues were $650 million, and GAAP operating income was $401 million from the third quarter of 2008. Third-quarter net income on a GAAP basis was $202 million and diluted earnings per share on a GAAP basis were $3.04.

The 2009 GAAP results reflect the operations of Chicago Mercantile Exchange (CME), Board of Trade of the City of Chicago (CBOT), and New York Mercantile Exchange (NYMEX) and include reductions in net income of $21 million, consisting of an impairment charge on our investment in IMAREX of $19 million and merger-related items of $2 million. The charge for IMAREX, a Norwegian-based freight and energy exchange and interdealer broker, was due to a decline in IMAREX fair value relative to the fair value established at the time of CME Group's acquisition of NYMEX in August 2008. The 2008 GAAP results reflect the operations of both CME and CBOT, as well as the results of NYMEX after August 22, 2008, when the acquisition closed.

Third-quarter pro forma non-GAAP diluted earnings per share were $3.35, down 19 percent compared with the prior-year period. All pro forma results reflect the operations of both CME Group and NYMEX as if they were combined for all periods reported, and third-quarter 2009 pro forma non-GAAP results exclude the impairment charge and merger-related items mentioned above. Total pro forma revenues decreased 17 percent from the prior year to $650 million and increased $2.6 million from second-quarter 2009 revenues. Pro forma operating expenses decreased 10 percent to $244 million, compared with the same period last year. Third-quarter pro forma operating income was $407 million, a decrease of 21 percent from $515 million for the year-ago period.

The company's significant focus on expense management during ongoing challenging market conditions helped drive a strong pro forma operating margin of 63 percent, in line with second-quarter 2009 operating margin, and down from 65 percent from the same period a year ago. Operating margin is defined as operating income as a percentage of total revenues. Third-quarter 2009 pro forma net income decreased 20 percent to $223 million, compared with third-quarter 2008.

All references to volume and rate per contract information in the text of this document exclude our non-traditional TRAKRS products, for which CME Group receives significantly lower clearing fees than other CME Group products, Swapstream, and HuRLO products.

Pro forma measures do not replace and are not a substitute for GAAP financial results. They are provided to improve overall understanding of current financial performance and to provide a meaningful comparison with prior periods. A full reconciliation of third-quarter and first-nine-months 2009 pro forma results to GAAP results is included with the attached financial statements.

"Building on solid third-quarter results, October has been a strong volume month, particularly in foreign exchange and energy," said CME Group Executive Chairman Terry Duffy. "As the economy continues to stabilize, there is room for further organic growth in our core business. At the same time, we are actively working to ensure that the benefits our business model brings to the financial system are communicated to the legislators and regulators who are charged with regulatory reform."

"As part of our global growth strategy, we have continued to invest in enhancing our global marketing and sales staff and expanding our CME ClearPort OTC clearing services across all asset classes," said CME Chief Executive Officer Craig Donohue. "During the quarter we also announced a partnership with Bursa Malaysia to extend our ability to deliver products and services to Asian customers. The strength of our core business and our capacity to deliver high quality, cleared-only offerings, coupled with strategic partnerships around the globe, such as Bursa Malaysia and BM&F Bovespa, position CME Group to compete effectively where, when, and how our customers want."

    CME Group Inc. Third-Quarter 2009 Results

    Financial Highlights:

    GAAP

      ($s in millions,
       except
       per share)        Q3 FY09   Q3 FY08     Y/Y  YTD FY09   YTD FY08    Y/Y
                         -------   -------     ---  --------   --------    ---
      Revenues             $650      $681      -4%   $1,945    $1,869       4%
      Expenses             $249      $260      -4%     $759      $705       8%
      Operating Income     $401      $421      -5%   $1,187    $1,164       2%
      Operating Margin %   61.7%     61.8%             61.0%     62.3%
      Net Income           $202      $169      20%     $623      $653      -5%
      Diluted EPS         $3.04     $2.81       8%    $9.37    $11.61     -19%


    Pro Forma Non-GAAP

      ($s in millions,
       except
       per share)       Q3 FY09   Q3 FY08      Y/Y  YTD FY09   YTD FY08    Y/Y
                        -------   -------      ---  --------   --------    ---
      Revenues            $650      $787      -17%   $1,945    $2,360     -18%
      Expenses            $244      $272      -10%     $739      $827     -11%
      Operating Income    $407      $515      -21%   $1,206    $1,532     -21%
      Operating Margin %  62.5%     65.5%              62.0%     64.9%
      Net Income          $223      $278      -20%     $660      $844     -22%
      Diluted EPS        $3.35     $4.13      -19%    $9.92    $12.59     -21%

    NOTE: See the CME Group Inc. Reconciliation of GAAP to Pro Forma Non-GAAP
    Measures for detail related to the adjustments made to reach the pro
    forma results.

Third-quarter 2009 average daily volume was 10.1 million contracts, down 23 percent compared with third-quarter 2008. Pro forma clearing and transaction fee revenue was $541 million, down from $665 million in third-quarter 2008, but up one percent from second-quarter 2009. The total pro forma average rate per contract for CME Group increased six percent from third-quarter 2008 to 83 cents, and increased one percent compared with 82 cents in second-quarter 2009. Quotation data fees were down 11 percent to $81 million in the third quarter due primarily to a decrease in screen counts associated with cost-cutting initiatives at customer firms.

Third-quarter 2009 pro forma non-operating expense was $26 million, driven primarily by interest expense and borrowing costs of $32 million related to the NYMEX acquisition, which was partially offset by $8 million of investment income. Additionally, the third-quarter 2009 effective tax rate was 41.4 percent, down from 43.3 percent in third-quarter 2008.

As of September 30, the company had $298 million of cash and marketable securities and $2.5 billion of debt. During the quarter, the company paid down approximately $450 million of debt.

CME Group will hold a conference call to discuss third-quarter 2009 results at 8:30 a.m. Eastern Time today. A live audio Webcast of the call will be available on the Investor Relations section of CME Group's Web site at www.cmegroup.com. An archived recording will be available for up to two months after the call.

CME Group (www.cmegroup.com) is the world's largest and most diverse derivatives marketplace. Building on the heritage of CME, CBOT and NYMEX, CME Group serves the risk management needs of customers around the globe. As an international marketplace, CME Group brings buyers and sellers together on the CME Globex electronic trading platform and on trading floors in Chicago and New York. By acting as the buyer to every seller and the seller to every buyer, CME Clearing virtually eliminates counterparty credit risk. CME Clearing also offers financial safeguards to help mitigate systemic risk, providing the security and confidence market participants need to operate, invest and grow. CME Group offers the widest range of benchmark products available across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, and alternative investment products such as weather and real estate. CME Group is listed on NASDAQ under the symbol "CME."

The Globe logo, CME, Chicago Mercantile Exchange, CME Group, Globex, E-mini and CME ClearPort are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade, Inc. are trademarks of the Board of Trade of the City of Chicago. NYMEX and New York Mercantile Exchange are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. All other trademarks are the property of their respective owners. Further information about CME Group (NASDAQ: CME) and its products can be found at www.cmegroup.com.

Statements in this press release that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. Among the factors that might affect our performance are: our ability to realize the benefits and control the costs of our merger with NYMEX Holdings, Inc. and our ability to successfully integrate the businesses of CME Group and NYMEX Holdings, including the fact that such integration may be more difficult, time consuming or costly than expected and revenues following the merger may be lower than expected and expected cost savings from the merger may not be fully realized within the expected time frames or at all; increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development and implementation of the enhanced functionality required by our customers; our ability to continue introducing competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to continue to generate revenues from our processing services; our ability to maintain existing customers, develop strategic relationships and attract new customers; our ability to expand and offer our products in foreign jurisdictions; changes in domestic and foreign regulations; changes in government policy, including policies relating to common or directed clearing, changes as a result of a harmonization of the regulation of the Securities and Exchange Commission and the U.S. Commodity Futures Trading Commission, or changes relating to the recently enacted or proposed legislation relating to the current economic crisis; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; our ability to generate revenue from our market data that may be reduced or eliminated by the growth of electronic trading or declines in subscriptions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our financial safeguards package to adequately protect us from the credit risks of clearing members; the ability of our compliance and risk management methods to effectively monitor and manage our risks; changes in price levels and volatility in the derivatives markets and in underlying fixed income, equity, foreign exchange and commodities markets; economic, political and market conditions, including the recent volatility of the capital and credit markets and the impact of current economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in trading volume and order transaction traffic without failure or degradation of performance of our systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks and control the costs associated with our acquisition, investment and alliance strategy; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry and customer consolidation; decreases in trading and clearing activity; the imposition of a transaction tax on futures and options on futures transactions; the unfavorable resolution of material legal proceedings, the seasonality of the futures business; and changes in the regulation of our industry with respect to speculative trading in commodity interests and derivatives contracts. More detailed information about factors that may affect our performance may be found in our filings with the Securities and Exchange Commission, including our most recent periodic reports filed on Form 10-K and Form 10-Q, which are available in the Investor Relations section of the CME Group Web site. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

CME-E


                        CME Group Inc. and Subsidiaries
                          Consolidated Balance Sheets
                                 (in millions)

                                                  September 30,   December 31,
                                                       2009           2008
                                                       ----           ----
    ASSETS
    Current Assets:
         Cash and cash equivalents                    $204.1        $297.9
         Collateral from securities lending                -         426.9
         Marketable securities, including pledged
          securities                                    93.7         310.1
         Accounts receivable, net of
          allowance                                    264.0         234.0
         Other current assets                          119.6         189.1
         Cash performance bonds and security
          deposits                                   6,824.8      17,653.5
                                                     -------      --------
    Total current assets                             7,506.2      19,111.5
    Property, net of accumulated
     depreciation and amortization                     726.9         707.2
    Intangible assets - trading products            16,982.0      16,982.0
    Intangible assets - other, net of
     accumulated amortization                        3,277.1       3,369.4
    Goodwill                                         7,549.3       7,519.2
    Other assets                                       478.1         469.4
                                                       -----         -----
    Total Assets                                   $36,519.6     $48,158.7
                                                   =========     =========

    LIABILITIES AND SHAREHOLDERS' EQUITY
    Current Liabilities:
         Accounts payable                              $36.1         $71.0
         Payable under securities lending
          agreements                                       -         456.8
         Short-term debt                               299.7         249.9
         Other current liabilities                     157.8         211.8
         Cash performance bonds and security
          deposits                                   6,824.8      17,653.5
                                                     -------      --------
    Total current liabilities                        7,318.4      18,643.0
    Long-term debt                                   2,239.3       2,966.1
    Deferred tax liabilities                         7,669.9       7,728.3
    Other liabilities                                  161.7         132.7
                                                       -----         -----
    Total Liabilities                               17,389.3      29,470.1
    Shareholders' equity                            19,130.3      18,688.6
                                                    --------      --------
    Total Liabilities and Shareholders'
     Equity                                        $36,519.6     $48,158.7
                                                   =========     =========



                          CME Group Inc. and Subsidiaries
                         Consolidated Statements of Income
       (dollars in millions, except per share amounts; shares in thousands)

                                            Quarter Ended   Nine Months Ended
                                            September 30,     September 30,
                                            2009    2008      2009      2008
                                            ----    ----      ----      ----
    Revenues
         Clearing and transaction fees     $540.6  $558.7  $1,605.2  $1,542.3
         Quotation data fees                 81.4    75.7     249.0     192.3
         Processing services                  0.1    17.9       0.3      53.9
         Access and communication fees       11.4    10.9      34.5      32.2
         Other                               16.9    17.7      56.3      48.5
                                             ----    ----      ----      ----
         Total Revenues                     650.4   680.9   1,945.3   1,869.2

    Expenses
         Compensation and benefits           87.3    84.5     262.0     231.4
         Communications                      11.5    11.5      35.5      39.1
         Technology support services         11.3    11.9      34.7      47.0
         Professional fees and outside
          services                           17.9    17.0      61.9      47.8
         Amortization of purchased
          intangibles                        30.7    29.1      94.5      63.2
         Depreciation and amortization       32.3    34.1      93.4     102.9
         Occupancy and building operations   19.1    18.9      57.3      52.9
         Licensing and other fee
          agreements                         21.2    19.3      67.5      44.8
         Restructuring                        0.6     0.1       5.2       2.1
         Other                               17.1    33.8      46.7      73.7
                                             ----    ----      ----      ----
         Total Expenses                     249.0   260.2     758.7     704.9

    Operating Income                        401.4   420.7   1,186.6   1,164.3

    Non-Operating Income and Expense
         Investment income                   10.5    18.0      22.4      41.4
         Impairment of long-term
          investment                        (22.4)      -     (22.4)        -
         Gains (losses) on derivative
          investments                           -     7.4         -      (7.8)
         Securities lending interest
          income                                -     8.6       2.8      32.2
         Securities lending interest and other
          costs                                 -   (28.9)     (0.1)    (48.2)
         Interest and other borrowing
          costs                             (32.1)  (17.9)   (103.2)    (21.6)
         Guarantee of exercise right
          privileges                            -     8.0         -      12.8
         Equity in losses of unconsolidated
          subsidiaries                       (1.6)  (20.0)     (4.5)    (27.9)
         Other income (expense)                 -     0.1      (0.4)     (8.4)
                                              ---     ---      ----      ----
         Total Non-Operating                (45.6)  (24.7)   (105.4)    (27.5)

    Income Before Income Taxes              355.8   396.0   1,081.2   1,136.8

    Income tax provision                   (153.5) (227.3)   (458.0)   (483.4)
                                           ------  ------    ------    ------
    Net Income                             $202.3  $168.7    $623.2    $653.4
                                           ======  ======    ======    ======

    Earnings per Common Share:
         Basic                              $3.05   $2.82     $9.39    $11.66
         Diluted                             3.04    2.81      9.37     11.61

    Weighted Average Number of Common Shares:
         Basic                             66,384  59,870    66,339    56,054
         Diluted                           66,573  60,086    66,514    56,302



                         CME Group Inc. and Subsidiaries
               Pro Forma Non-GAAP Consolidated Statements of Income
       (dollars in millions, except per share amounts; shares in thousands)

                                           Quarter Ended   Nine Months Ended
                                           September 30,     September 30,
                                           2009    2008      2009      2008
                                           ----    ----      ----      ----
    Revenues
         Clearing and transaction fees    $540.6  $665.2  $1,605.2  $2,008.2
         Quotation data fees                81.4    91.6     249.0     261.4
         Processing services                 0.1     0.6       0.3       1.6
         Access and communication fees      11.4    11.1      34.5      33.0
         Other                              16.9    18.3      56.3      55.6
                                            ----    ----      ----      ----
         Total Revenues                    650.4   786.8   1,945.3   2,359.8

    Expenses
         Compensation and benefits          84.5    93.4     257.9     277.5
         Communications                     11.5    12.1      35.5      42.3
         Technology support services        11.3    13.1      34.7      52.6
         Professional fees and outside
          services                          16.4    18.4      56.2      56.2
         Amortization of purchased
          intangibles                       30.5    31.3      91.4      92.4
         Depreciation and amortization      32.3    34.8      93.4     105.5
         Occupancy and building
          operations                        19.1    21.2      57.3      63.9
         Licensing and other fee
          agreements                        21.2    25.2      67.5      70.7
         Other                              16.8    22.3      45.5      66.3
                                            ----    ----      ----      ----
         Total Expenses                    243.6   271.8     739.4     827.4

    Operating Income                       406.8   515.0   1,205.9   1,532.4

    Non-Operating Income and Expense
         Investment income                   7.7    22.4      18.3      54.7
         Gains (losses) on derivative
          investments                          -     0.1         -       0.2
         Securities lending interest
          income                               -    10.5       2.8      46.7
         Securities lending interest and
          other costs                          -   (15.0)     (0.1)    (44.7)
         Interest and other borrowing
          costs                            (32.1)  (38.1)   (103.2)   (114.3)
         Equity in losses of unconsolidated
          subsidiaries                      (1.6)   (5.1)     (4.5)    (17.2)
                                            ----    ----      ----     -----
         Total Non-Operating               (26.0)  (25.2)    (86.7)    (74.6)

    Income Before Income Taxes             380.8   489.8   1,119.2   1,457.8

    Income tax provision                  (157.8) (212.0)   (459.3)   (613.7)
                                          ------  ------    ------    ------
    Net Income                            $223.0  $277.8    $659.9    $844.1
                                          ======  ======    ======    ======

    Earnings per Diluted Common Share      $3.35   $4.13     $9.92    $12.59

    Weighted Average Number of Diluted
     Common Shares(1)                     66,573  67,325    66,514    67,062

    Note:  All pro forma results for CME Group assume the acquisition of
    NYMEX was completed as of the beginning of the period presented.  See
    CME Group Inc. Reconciliation of GAAP to Pro Forma Non-GAAP Measures for
    detail on all of the adjustments made to reach the pro forma results.

    (1) Weighted average number of diluted common shares includes
        merger-related shares converted or issued for the entire
        period reported.



                         CME Group Inc. and Subsidiaries
              Reconciliation of GAAP to Pro Forma Non-GAAP Measures
                                  (in millions)

                                          Quarter Ended   Nine Months Ended
                                          September 30,      September 30,
                                          2009     2008      2009      2008
                                          ----     ----      ----      ----
    GAAP Results
    Revenues                             $650.4   $680.9  $1,945.3  $1,869.2
    Expenses                              249.0    260.2     758.7     704.9
                                          -----    -----     -----     -----
    Operating income                      401.4    420.7   1,186.6   1,164.3

    Non-operating income and expense      (45.6)   (24.7)   (105.4)    (27.5)
                                          -----    -----    ------     -----
    Income before income taxes            355.8    396.0   1,081.2   1,136.8
    Income tax provision                 (153.5)  (227.3)   (458.0)   (483.4)
                                         ------   ------    ------    ------
         Net Income                      $202.3   $168.7    $623.2    $653.4
                                         ======   ======    ======    ======


    Pro Forma Adjustments
    Revenues:
    NYMEX pre-merger revenue                 $-   $124.3        $-    $544.0
    Intercompany revenue elimination(1)       -    (10.7)        -     (45.7)
    FXMarketSpace write down                  -     (7.7)        -      (7.7)
                                            ---     ----       ---      ----
    Total Pro Forma Revenue Adjustment        -    105.9         -     490.6

    Expenses:
    NYMEX pre-merger expense                  -     81.5         -     229.2
    Intercompany expense elimination (1)      -    (10.8)        -     (45.8)
    Deferred compensation gain/loss
     reclass(2)                            (2.8)     2.9      (4.1)      4.5
    Swapstream write down                  (0.3)   (14.3)     (0.3)    (14.3)
    Amortization of intangibles (3)           -      5.6      (2.8)     32.6
    Depreciation adjustment from
     building life change (4)                 -      1.0         -       4.0
    Loss on sale of metals                    -     (2.8)        -      (2.8)
    FXMarketSpace write down                  -     (2.6)        -      (2.6)
    Other (5)                              (2.3)   (48.9)    (12.1)    (82.3)
                                           ----    -----     -----     -----
    Total Pro Forma Expense Adjustment     (5.4)    11.6     (19.3)    122.5
                                           ----     ----     -----     -----

    Adjustment to operating income          5.4     94.3      19.3     368.1

    Non-operating income and expense:
    NYMEX premerger non-operating income      -     (0.3)        -      32.4
    Interest on debt acquired for NYMEX
     deal                                     -    (19.3)        -     (88.6)
    Deferred compensation gain/loss
     reclass(2)                            (2.8)     2.9      (4.1)      4.5
    Equity investment unusual gain/
     loss(6)                                  -     15.9         -     (14.7)
    Securities lending writedown              -     15.7         -      15.7
    ERP Guarantee (7)                         -     (8.0)        -     (12.8)
    BM&F Bovespa (8)                          -     (7.4)        -      16.4
    Green Exchange(9)                         -        -       0.4         -
    IMAREX impairment                      22.4        -      22.4         -
                                           ----      ---      ----       ---
    Total Pro Forma Non-Operating Income
     and Expense Adjustment                19.6     (0.5)     18.7     (47.1)
                                           ----     ----      ----     -----
    Adjustment to income before income
     taxes                                 25.0     93.8      38.0     321.0
    Adjustment to income tax provision     (4.3)    15.3      (1.3)   (130.3)
                                           ----     ----      ----    ------
         Adjustment to net income         $20.7    109.1     $36.7    $190.7
                                          =====    =====     =====    ======


    Pro Forma Non-GAAP Results
    Revenues                              650.4    786.8   1,945.3   2,359.8
    Expenses                              243.6    271.8     739.4     827.4
                                         ------   ------    ------    ------
    Operating income                      406.8    515.0   1,205.9   1,532.4

    Non-operating income and expense      (26.0)   (25.2)    (86.7)    (74.6)
                                          -----   ------     -----     -----
    Income before income taxes            380.8    489.8   1,119.2   1,457.8
    Income tax provision(10)             (157.8)  (212.0)   (459.3)   (613.7)
                                         ------  -------    ------    ------
         Net Income                      $223.0   $277.8    $659.9    $844.1
                                          =====   ======     =====     =====

    Notes:
    (1)  Eliminate processing services provided prior to the NYMEX
         acquisition.
    (2)  Remove gains and losses related to a deferred compensation plan
         that are recorded in compensation with a corresponding offset in
         investment income.
    (3)  Add amortization of intangible assets recorded in purchase of
         NYMEX.
    (4)  Adjust depreciation for changes in value and useful life of
         building acquired from NYMEX.
    (5)  Reverse effect of restructuring, accelerated depreciation,
         integraton and legal expenses related to the merger with CBOT
         and the acquisition of NYMEX.  Also removes other merger-related
         transaction costs that were expensed and transaction costs related
         to the acquisition of CMA.
    (6)  Write-down of Optionable as well as a gain related to TSX Group.
    (7)  Reverse impact of exercise right privilege guarantee.
    (8)  Reverse derivative gains/losses and transaction costs related to the
         BM&F/Bovespa investment.
    (9)  Reverse transaction costs related to the investment in Green
         Exchange.
    (10) Pro forma adjustments are tax effected at CME Group's estimated
         statutory tax rate.



                                  CME Group Inc.
                          Quarterly Operating Statistics

                                       3Q 2008 4Q 2008 1Q 2009 2Q 2009 3Q 2009
                                       ------- ------- ------- ------- -------
    Trading Days                            64      64      61      63      64



                       Quarterly Average Daily Volume (ADV)

     CME Group ADV (Legacy CME, CBOT, NYMEX and COMEX combined, in thousands)

    Product Line                       3Q 2008 4Q 2008 1Q 2009 2Q 2009 3Q 2009
    ------------                       ------- ------- ------- ------- -------
    Interest rates                       6,030   3,692   3,843   4,389   4,422
    Equities                             3,842   3,993   3,537   2,988   2,656
    Foreign exchange                       710     481     507     568     660
    Energy (including ClearPort)         1,475   1,290   1,524   1,396   1,484
    Commodities & alternative
     investments                           822     691     685     818     708
    Metals (including ClearPort)           265     184     215     190     201
                                           ---     ---     ---     ---     ---
         Total                          13,145  10,331  10,311  10,349  10,132

    Venue
    -----
    Open outcry                          1,811   1,456   1,338   1,431   1,264
    Electronic                          10,686   8,272   8,223   8,266   8,267
    Privately negotiated                   203     168     164     173     147
                                           ---     ---     ---     ---     ---
    Exchange-traded Total               12,700   9,895   9,726   9,871   9,679
    CME ClearPort                          445     436     586     478     453
                                           ---     ---     ---     ---     ---
         Total                          13,145  10,331  10,311  10,349  10,132


                          Average Rate Per Contract (RPC)

            CME Group RPC (Legacy CME, CBOT, NYMEX and COMEX combined)

    Product Line                       3Q 2008 4Q 2008 1Q 2009 2Q 2009 3Q 2009
    ------------                       ------- ------- ------- ------- -------
    Interest rates                      $0.521  $0.569  $0.532  $0.525  $0.505
    Equities                             0.720   0.748   0.716   0.712   0.722
    Foreign exchange                     0.936   0.894   0.918   0.901   0.853
    Energy (including ClearPort)         1.629   1.773   1.608   1.653   1.694
    Commodities & alternative
     investments                         1.154   1.154   1.108   1.130   1.199
    Metals (including ClearPort)         1.762   1.879   1.858   1.808   1.849
                                         -----   -----   -----   -----   -----
         Average RPC                    $0.790  $0.866  $0.839  $0.823  $0.834

    Venue
    -----
    Exchange-traded                     $0.743  $0.801  $0.777  $0.765  $0.765
    CME ClearPort                        2.139   2.352   1.874   2.031   2.304


    Note:  All CME Group volume and rate per contract data is based upon pro
    forma results, including the operations of CME Group and NYMEX as if they
    were combined for the entire period reported.  All data excludes our non-
    traditional TRAKRS products, for which CME Group receives significantly
    lower clearing fees than other CME Group products.  Additionally, all
    data excludes Swapstream and HuRLO products.

    Note:  Average daily volume and rate per contract figures for prior
    periods have been revised due to standardizing NYMEX reporting
    conventions to follow CME Group's treatment of post-trade transactions
    such as exercises, assignments and deliveries.


SOURCE: CME Group Inc.

Web site: http://www.cmegroup.com/

Corporate Communications

+1 312 930 3434
Email